EyePoint Pharmaceuticals
EYPT
EYPT
141 hedge funds and large institutions have $649M invested in EyePoint Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
7.62% less ownership
Funds ownership: 107.77% → 100.15% (-7.6%)
30% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 30
75% less call options, than puts
Call options by funds: $2.85M | Put options by funds: $11.4M
Holders
141
Holding in Top 10
4
Calls
$2.85M
Puts
$11.4M
Top Buyers
| 1 | +$7.53M | |
| 2 | +$5.65M | |
| 3 | +$4.84M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.21M |
| 5 |
SC
Stempoint Capital
New York
|
+$3.1M |
Top Sellers
| 1 | -$17.2M | |
| 2 | -$12M | |
| 3 | -$8.33M | |
| 4 |
FC
Finepoint Capital
Boston,
Massachusetts
|
-$5.86M |
| 5 |
BlackRock
New York
|
-$3.4M |
